Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -.--% |
2017 | Entia Biosciences, Inc. Announces Management Changes | CI |
2017 | Entia Biosciences, Inc Auditor Raises 'Going Concern' Doubt | CI |
Sales 2015 | 3L 2.9Cr | Sales 2016 | 3L 2.22Cr | Capitalization | 15.76L 13Cr |
---|---|---|---|---|---|
Net income 2015 | -20L -17Cr | Net income 2016 | -10L -8.35Cr | EV / Sales 2015 | 8.29 x |
Net Debt 2015 | 3L 2.13Cr | Net Debt 2016 | 10L 8.1Cr | EV / Sales 2016 | 9.59 x |
P/E ratio 2015 |
-0.97
x | P/E ratio 2016 |
-1.13
x | Employees | 7 |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 99.44% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 67 | 01/15/01 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 3.41T | |
+26.37% | 4.5TCr | |
-1.01% | 4.26TCr | |
+46.00% | 4.18TCr | |
-5.31% | 2.9TCr | |
+9.34% | 2.61TCr | |
-21.69% | 1.9TCr | |
+6.23% | 1.28TCr | |
+26.99% | 1.21TCr | |
-3.38% | 1.18TCr |
- Stock Market
- Equities
- ERGO Stock